Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma

N/AActive Not RecruitingNCT07201415

Zhongnan Hospital30 enrolled

Overview

To explore the efficacy and safety of minimally invasive suprachoroidal drainage for the treatment of advanced neovascular glaucoma

To explore the efficacy and safety of minimally invasive supraporcular drainage in the treatment of advanced neovascular glaucoma, and to record the various basic diseases, ocular conditions, lifestyle, inflammatory markers and other parameters of NVG patients. To compare the safety and efficacy of new surgical methods and traditional surgical methods in order to find an effective treatment for neovascular glaucoma

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Neovascular Glaucoma

Interventions

minimally invasive suprachoroidal drainagePROCEDURE

minimally invasive suprachoroidal drainage

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Advanced (angle-closure) neovascular glaucoma with poorly controlled intraocular pressure (IOP \> 21mmHg) after medical or surgical treatment Exclusion Criteria: * Various other types of glaucoma (including primary open-angle glaucoma, primary open-closed glaucoma, normal tension glaucoma, juvenile glaucoma, congenital glaucoma, other special types of glaucoma, etc.) * Eye infection within two weeks before surgery * Non-glaucomatous intraocular diseases that affect intraocular pressure (choroidal hemorrhage or detachment, retinal detachment, lens subluxation, thyroid eye disease, clinically significant macular edema, eye tumors, etc.) * Visual acuity of non-study eyes \< 0.05 * Congenital or acquired factors lead to ciliary body anatomical abnormalities

Locations (1)

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, China